Quanterix (NASDAQ:QTRX) Announces Earnings Results

Quanterix (NASDAQ:QTRX) issued its quarterly earnings results on Monday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The company had revenue of $35.16 million for the quarter, compared to analyst estimates of $34.93 million. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Trading Up 3.1 %

Shares of Quanterix stock opened at $7.28 on Tuesday. Quanterix has a 12-month low of $6.80 and a 12-month high of $27.37. The firm has a market capitalization of $280.45 million, a price-to-earnings ratio of -6.87 and a beta of 1.34. The firm’s 50 day simple moving average is $8.50 and its two-hundred day simple moving average is $10.97.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.